E-LIB Suche - Ergebnisse für: Strober, Bruce

1

Efficacy of long‐term risankizumab treatment for moderate‐t..:

Strober, Bruce ; Bachelez, Hervé ; Crowley, Jeffrey...
Journal of the European Academy of Dermatology and Venereology. 38 (2024) 5 - p. 864-872 , 2024

Link: https://doi.org/10.1111/..

2

Deucravacitinib, a selective, allosteric tyrosine kinase 2 ..:

Blauvelt, Andrew ; Rich, Phoebe ; Sofen, Howard...
Journal of the American Academy of Dermatology. 90 (2024) 4 - p. 775-782 , 2024

Link: https://doi.org/10.1016/..

3

Deucravacitinib in Plaque Psoriasis: 3-year Safety and Effi..:

Armstrong, April W. ; Lebwohl, Mark ; Warren, Richard B....
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s366 , 2024

Link: https://doi.org/10.25251..

4

A randomized, double-blinded, phase 2 trial of EDP1815, an ..:

Ehst, Benjamin D. ; Strober, Bruce ; Blauvelt, Andrew...
Frontiers in Medicine. 11 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

5

Effect of High-Dose Subcutaneous Spesolimab on Skin Manifes..:

Strober, Bruce ; Augustin, Matthias ; Tada, Yayoi...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s371 , 2024

Link: https://doi.org/10.25251..

6

Mental health outcomes in patients with moderate to severe ..:

Blauvelt, Andrew ; Armstrong, April ; Merola, Joseph F....
Journal of the American Academy of Dermatology. , 2024

Link: https://doi.org/10.1016/..

7

P170 Ixekizumab significantly improved quality of life and ..:

Ritchlin, Christopher ; Kavanaugh, Arthur ; Kristensen, Lars Erik...
Rheumatology. 63 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

8

Bimekizumab safety in moderate to severe plaque psoriasis: ..:

Lebwohl, Mark ; Merola, Joseph F. ; Strober, Bruce...
Journal of the American Academy of Dermatology. , 2024

Link: https://doi.org/10.1016/..

9

Characterization of disease burden, treatment and comorbidi..:

Silverberg, Jonathan I. ; Cronin, Angel ; Jones, Eric A....
JAAD International. 15 (2024) - p. 127-130 , 2024

Link: https://doi.org/10.1016/..

10

Spesolimab treatment for the prevention of flares in people..:

Morita, Akimichi ; Strober, Bruce ; Burden, A David...
Future Rare Diseases. 4 (2024) 1 - p. , 2024

Link: https://doi.org/10.2217/..

11

Association of the clinical components in the distal interp..:

McGonagle, Dennis ; Kavanaugh, Arthur ; McInnes, Iain B...
Rheumatology. , 2024

Link: https://doi.org/10.1093/..

12

Real-world effectiveness of risankizumab in patients with m..:

Strober, Bruce ; Ferris, Laura ; Callis Duffin, Kristina...
Journal of the American Academy of Dermatology. 90 (2024) 1 - p. 82-90 , 2024

Link: https://doi.org/10.1016/..

13

Bimekizumab 3-year Safety and Tolerability in Moderate to S..:

Lebwohl, Mark ; Strober, Bruce ; Langley, Richard G....
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s305 , 2024

Link: https://doi.org/10.25251..

14

Measuring GPPGA, Pain, Symptom, and Quality of Life Index S..:

Strober, Bruce ; Mostaghimi, Arash ; Anadkat, Milan...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s361 , 2024

Link: https://doi.org/10.25251..

15

503 - Visualizing 3-year treatment outcome trajectories of ..:

Wang, Zhixiao ; Martins, Bruno ; Ardeleanu, Marius...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii9-ii9 , 2024

Link: https://doi.org/10.1093/..